Ever Source Wealth Advisors, LLC Crinetics Pharmaceuticals, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 87 shares of CRNX stock, worth $2,889. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87
Previous 77
12.99%
Holding current value
$2,889
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CRNX
# of Institutions
254Shares Held
89.2MCall Options Held
26.1KPut Options Held
11.8K-
Vanguard Group Inc Valley Forge, PA9.09MShares$302 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.95MShares$231 Million0.07% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$207 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.14MShares$204 Million3.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.41MShares$180 Million0.03% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.79B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...